Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

FBXO25 Inhibitors

FBXO25 inhibitors belong to a class of compounds designed to selectively impede the activity of the F-box only protein 25 (FBXO25), a critical component of the Skp1-Cullin 1-F-box protein (SCF) ubiquitin ligase complex. The SCF complex plays a pivotal role in the ubiquitin-proteasome system, orchestrating the targeted degradation of specific proteins by labeling them with ubiquitin molecules. FBXO25, as the F-box protein within this complex, acts as a substrate recognition subunit, determining the specificity of substrate ubiquitination. Inhibitors targeting FBXO25 aim to disrupt this regulatory mechanism, thereby modulating the stability and abundance of specific proteins involved in various cellular processes. FBXO25 inhibitors are designed with a focus on selectively binding to the active site or critical regions of FBXO25, preventing its interaction with substrates and subsequent ubiquitination. The development of these inhibitors involves a thorough understanding of the structural and biochemical characteristics of FBXO25, allowing for the rational design of molecules with high affinity and specificity for the target. Inhibiting FBXO25 holds potential for influencing cellular pathways that are tightly regulated by the SCF complex, making these compounds valuable tools for investigating the intricacies of protein degradation in cellular homeostasis and signaling.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

A peptide aldehyde that inhibits the proteasome, thus can prevent the degradation of proteins targeted by FBXO25.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

A boronic acid derivative that inhibits the 26S proteasome, potentially increasing the levels of proteins marked for degradation by FBXO25.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

A β-lactone that irreversibly inhibits proteasome activity, could lead to accumulation of FBXO25 substrates.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$137.00
$219.00
$449.00
$506.00
19
(2)

A specific proteasome inhibitor that covalently binds to and inhibits the chymotrypsin-like activity of the proteasome, affecting FBXO25 function indirectly.

MLN 4924

905579-51-3sc-484814
1 mg
$286.00
1
(0)

An inhibitor of NEDD8-activating enzyme, it prevents neddylation, which is necessary for the activity of the cullin-RING ligase complex that includes FBXO25.

Ubiquitin E1 Inhibitor, PYR-41

418805-02-4sc-358737
25 mg
$360.00
4
(1)

An inhibitor of the ubiquitin-activating enzyme E1, could indirectly affect FBXO25 by disrupting ubiquitin conjugation to target proteins.

IU1

314245-33-5sc-361215
sc-361215A
sc-361215B
10 mg
50 mg
100 mg
$138.00
$607.00
$866.00
2
(0)

A specific inhibitor of the deubiquitinating enzyme USP14, can affect proteasome-associated deubiquitination that indirectly involves FBXO25 activity.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$111.00
$357.00
8
(0)

A glutarimide that indirectly inhibits the E3 ubiquitin ligase activity of cereblon, a protein that can intersect with FBXO25's pathways.

Nutlin-3

548472-68-0sc-45061
sc-45061A
sc-45061B
1 mg
5 mg
25 mg
$62.00
$225.00
$779.00
24
(1)

A compound that inhibits MDM2, an E3 ubiquitin-protein ligase, which can intersect with FBXO25-mediated ubiquitination processes.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

An antimalarial drug that can alkalize the lysosomal pH, potentially affecting the degradation of proteins that FBXO25 targets for ubiquitination.